UNSPSC 51281904: Olivomycin

This classification denotes a dna minor groove binding agent and antineoplastic antibiotic with the molecular formula C58H84O26, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 44003517D1, chemically known as olivomycin d, 3(b)-o-(2,6-dideoxy-3-c-methyl-4-o-(2-methyl-1-oxopropyl)-alpha-l-arabino-hexopyranosyl)- but generally known as olivomycin, which bears US NIH Compound Identifier 122806. European Medicines Agency schedules Olivomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03507MIG.

I have reviewed the source material provided. The UNSPSC 51281904 Olivomycin Commodity code shows no recent state and local contract opportunities in the data block. Without posted RFP, RFQ, IFB, or ITB notices from state agencies, counties, cities, school districts, transit authorities, or other state or local public bodies, I cannot characterize the issuing-body mix, geographic spread, or representative recent solicitations that would ground a business development assessment.

Olivomycin is a pharmaceutical agent with limited application in state and local government procurement. State health agencies, correctional systems, and healthcare authorities may acquire it through standing contracts or cooperative purchasing vehicles, but no current public notices support an analysis of activity under this code. Without evidence of active market solicitation, I cannot provide the concrete framing of work actually being bought that would inform a pursue-or-skip decision.